Transgenomic

 

Leaders in the Translation of
Molecular Genetics into Clinical Practice

Transgenomic Labs

Introduces CRC RAScan™
Colorectal Cancer Tumor Testing

First Dedicated Test to More Accurately Detect the Full Range of KRAS and NRAS Mutations
Relevant to Poor Response to EGFR Inhibitors

Transgenomic

FAMILION® Genetic Tests
for Inherited Cardiac Syndromes

Transgenomic

Expert Clinical Genetic Testing for Mitochondrial Genome, Epilepsy, Chromosomal Abnormalities and Other Inherited Diseases

Transgenomic

Highly Sensitive Oncology Testing Utilizing Proprietary Methods for Specific Mutation Analysis

Transgenomic

C-GAAP

The only simple saliva test that identifies patients who cannot completely absorb or activate
clopidogrel due to reduced function versions of the CYP2C19 and ABCB1 genes.

Transgenomic

 Now Available SCOLISCORE™

The SCOLISCORE™ AIS Prognostic Test
is the first clinically validated and highly
accurate prognostic test for AIS curve progression

1
2
3
4
5
6
7

Contact Us

Transgenomic, Inc.
Five Science Park
New Haven, CT 06511

Client Services: 1.877.274.9432
Fax: 1.855.263.8668
E-mail: clientservices [-- at --] transgenomic [dot] com

Select Country

Copyright © 1997-2012 Transgenomic, Inc., All Rights Reserved.

Site Map